Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway

Por La Paglia, Laura, Listì, Angela, Caruso, Stefano, Amodeo, Valeria, Passiglia, Francesco, Bazan, Viviana, Fanale, Daniele
Publicado no PPAR Res (2017)

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib

Por Corrales, Luis, Nogueira, Amanda, Passiglia, Francesco, Listi, Angela, Caglevic, Christian, Giallombardo, Marco, Raez, Luis, Santos, Edgardo, Rolfo, Christian
Publicado no Front Med (Lausanne) (2017)

Multisciplinary management of patients with liver metastasis from colorectal cancer

Por De Greef, Kathleen, Rolfo, Christian, Russo, Antonio, Chapelle, Thiery, Bronte, Giuseppe, Passiglia, Francesco, Coelho, Andreia, Papadimitriou, Konstantinos, Peeters, Marc
Publicado no World J Gastroenterol (2016)

Nintedanib in NSCLC: evidence to date and place in therapy

Por Bronte, Giuseppe, Passiglia, Francesco, Galvano, Antonio, Barraco, Nadia, Listì, Angela, Castiglia, Marta, Rizzo, Sergio, Fiorentino, Eugenio, Bazan, Viviana, Russo, Antonio
Publicado no Ther Adv Med Oncol (2016)

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Por Passiglia, Francesco, Bronte, Giuseppe, Bazan, Viviana, Natoli, Clara, Rizzo, Sergio, Galvano, Antonio, Listì, Angela, Cicero, Giuseppe, Rolfo, Christian, Santini, Daniele, Russo, Antonio
Publicado no Oncotarget (2016)

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

Por Bronte, Giuseppe, Silvestris, Nicola, Castiglia, Marta, Galvano, Antonio, Passiglia, Francesco, Sortino, Giovanni, Cicero, Giuseppe, Rolfo, Christian, Peeters, Marc, Bazan, Viviana, Fanale, Daniele, Giordano, Antonio, Russo, Antonio
Publicado no Oncotarget (2015)

ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it

Por Rolfo, Christian, Passiglia, Francesco, Castiglia, Marta, Raez, Luis E., Germonpre, Paul, Gil-Bazo, Ignacio, Zwaenepoel, Karen, De Wilde, Annemieke, Bronte, Giuseppe, Russo, Antonio, Van Meerbeeck, Jan P., Van Schil, Paul, Pauwels, Patrick
Publicado no Transl Lung Cancer Res (2014)

Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?

Por Fanale, Daniele, Bronte, Giuseppe, Passiglia, Francesco, Calò, Valentina, Castiglia, Marta, Di Piazza, Florinda, Barraco, Nadia, Cangemi, Antonina, Catarella, Maria Teresa, Insalaco, Lavinia, Listì, Angela, Maragliano, Rossella, Massihnia, Daniela, Perez, Alessandro, Toia, Francesca, Cicero, Giuseppe, Bazan, Viviana
Publicado no Anal Cell Pathol (Amst) (2015)

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR statu...

Por Bronte, Giuseppe, Franchina, Tindara, Alù, Massimiliano, Sortino, Giovanni, Celesia, Claudia, Passiglia, Francesco, Savio, Giuseppina, Laudani, Agata, Russo, Alessandro, Picone, Antonio, Rizzo, Sergio, De Tursi, Michele, Gambale, Elisabetta, Bazan, Viviana, Natoli, Clara, Blasi, Livio, Adamo, Vincenzo, Russo, Antonio
Publicado no Oncotarget (2016)